What evidence does the article provide that investor sentiment toward healthcare stocks has shifted positively in recent months?

The article states that the S&P 500 healthcare index (.SPXHC) rose 11.2% in the past three months to a record high—outpacing the S&P 500's 6% gain—and that U.S.-listed healthcare funds attracted $2.44 billion in July, extending June's $1.5 billion inflow and reversing three months of net withdrawals; additionally, Bank of America’s survey showed global fund managers were net 32% 'overweight' on healthcare in July, up sharply from 14% in June.

According to the article, what are the key drivers behind the renewed interest in healthcare stocks?

The article identifies three main drivers: improving earnings expectations (with double-digit growth forecast for S&P 500 healthcare companies from Q4 2026 through 2027, reversing a 16.7% contraction in Q2 2026), surging M&A activity (nearly $284 billion in deal value this year, approaching 2025’s $306 billion total and exceeding every year since 2021), and attractive valuations (trading at ~18x forward earnings—above its 20-year average of 15x but below the S&P 500’s ~20x).

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Aug 5, 2026

Investors are shifting capital into U.S. healthcare stocks, driving the S&P 500 healthcare index to record highs amid rising M&A activity and strong earnings forecasts from major drugmakers like AbbVie and AstraZeneca.

reuters

2026-08-05

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

FAQ